Conditioning with fludarabine and targeted busulfan before transplantation of allogeneic hematopoietic stem cells.

被引：0
|
作者：
Bornhaeuser, M
Storer, B
Slattery, JT
Appelbaum, FR
Deeg, HJ
Hansen, J
McDonald, G
Martin, PJ
Nichols, G
Radich, J
Woolfrey, A
Schleyer, E
Jenke, A
Thiede, C
Ehninger, G
Anasetti, C
机构：
[1] Univ Hosp Carl Gustav Carus, Med Klin & Poliklin 1, Dresden, Germany
[2] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
799
引用
收藏
页码：213A / 213A
页数：1
相关论文
共 50 条
  • [31] Conditioning with busulfan and fludarabine for allogeneic haematopoietic stem cell transplantation in children with acute myeloid leukaemia: a comparison to busulfan and cyclophosphamide
    Lee, S. H.
    Cheuh, H.
    Yoo, K. H.
    Sung, K. W.
    Koo, H. H.
    Lee, J. W.
    Kim, H.
    Kang, H. J.
    Park, K. D.
    Shin, H. Y.
    Ahn, H. S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S139 - S139
  • [32] Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study
    Jiang, Jieling
    Li, Xiaofan
    Wu, Dong
    Lu, Quanyi
    Miao, Kourong
    Wang, Houcai
    Li, Xiaoping
    Chen, Yingnian
    Zhou, Shiyuan
    Zhou, Yali
    Liao, Guiping
    Jiang, Chuanhe
    Yuan, Xiaohong
    Zhao, Youshan
    Chang, Chunkang
    Chen, Jie
    Zhu, Han
    Ma, Ruye
    Li, Nainong
    Yin, Xiaolin
    Wu, Xiaojin
    Wang, Sanbin
    Wang, Chun
    Hu, Jiong
    EJHAEM, 2024, 5 (04): : 757 - 767
  • [33] Treosulfan/fludarabine - a low toxicity but myeloablative conditioning for allogeneic hematopoietic stem cell transplantation
    Holowiecki, J
    Giebel, S
    Wojnar, J
    Krawczyk-Kulis, M
    Wylezol, I
    Kruzel, T
    Markiewicz, M
    BLOOD, 2004, 104 (11) : 292A - 292A
  • [34] Targeting once-daily intravenous busulfan in combination with fludarabine before allogeneic hematopoietic cell transplantation
    A Jenke
    J Freiberg-Richter
    C Johne
    H Knoth
    E Schleyer
    G Ehninger
    M Bornhäuser
    Bone Marrow Transplantation, 2005, 35 : 627 - 628
  • [35] Reduced-intensity conditioning with treosulfan and fludarabine for allogeneic hematopoietic stem cell transplantation
    Nihtinen, A
    Volin, L
    Juvonen, E
    Ruutu, T
    BONE MARROW TRANSPLANTATION, 2003, 31 : S159 - S159
  • [36] Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan -Fludarabine and Busulfan-Fludarabine Conditioning Have Similar Efficacy in Patients=65 Years Old or Those with Comorbidities
    Henig, Israel J.
    Geller, Ohad
    Yehudai-Ofir, Dana
    Krayem, Baher
    Frisch, Avraham
    Khatib, Hazim
    Zuckerman, Tsila
    BLOOD, 2023, 142
  • [37] Targeting once-daily intravenous busulfan in combination with fludarabine before allogeneic hematopoietic cell transplantation
    Jenke, A
    Freiberg-Richter, J
    Johne, C
    Knoth, H
    Schleyer, E
    Ehninger, G
    Bornhäuser, M
    BONE MARROW TRANSPLANTATION, 2005, 35 (06) : 627 - 628
  • [38] Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation
    Remberger, Mats
    Torlen, Johan
    El Serafi, Ibrahim
    Garming-Legert, Karin
    Bjorklund, Andreas
    Ljungman, Per
    Sundin, Mikael
    Hassan, Moustapha
    Mattsson, Jonas
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (04) : 471 - 475
  • [39] Once daily intravenous busulfan as part of a busulfan/cyclophosphamide conditioning regimen for allogeneic hematopoietic stem cell transplantation
    Mates, M
    Michalska, H
    Hasegawa, W
    Kiss, T
    Daly, A
    Loach, D
    Messner, H
    Lipton, J
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 36 - 36
  • [40] Delayed veno-occlusive disease after busulfan/fludarabine conditioning for allogeneic stem cell transplantation
    Pai, R. K.
    Van Besien, K.
    Artz, A.
    Hart, J.
    MODERN PATHOLOGY, 2008, 21 : 313A - 313A
12345